Authors:
TAKATSUKI F
MIYASAKA Y
KIKUCHI T
SUZUKI M
HAMURO J
Citation: F. Takatsuki et al., IMPROVEMENT OF ERYTHROID TOXICITY BY LENTINAN AND ERYTHROPOIETIN IN MICE TREATED WITH CHEMOTHERAPEUTIC-AGENTS, Experimental hematology, 24(3), 1996, pp. 416-422
Citation: J. Hamuro et al., CANCER CELL PROGRESSION AND CHEMOIMMUNOTHERAPY - DUAL EFFECTS IN THE INDUCTION OF RESISTANCE TO THERAPY, British Journal of Cancer, 73(4), 1996, pp. 465-471
Authors:
TAKATSUKI F
NAMIKI R
KIKUCHI T
SUZUKI M
HAMURO J
Citation: F. Takatsuki et al., LENTINAN AUGMENTS SKIN REACTION INDUCED BY BRADYKININ - ITS CORRELATION WITH VASCULAR DILATATION AND HEMORRHAGE RESPONSES AND ANTITUMOR ACTIVITIES, International journal of immunopharmacology, 17(6), 1995, pp. 465
Authors:
SUZUKI M
IWASHIRO M
TAKATSUKI F
KURIBAYASHI K
HAMURO J
Citation: M. Suzuki et al., RECONSTITUTION OF ANTITUMOR EFFECTS OF LENTINAN IN NUDE-MICE - ROLES OF DELAYED-TYPE HYPERSENSITIVITY REACTION TRIGGERED BY CD4-POSITIVE T-CELL CLONE IN THE INFILTRATION OF EFFECTOR-CELLS INTO TUMOR, Japanese journal of cancer research, 85(4), 1994, pp. 409-417
Authors:
HAMURO J
TAKATSUKI F
SUGA T
KIKUCHI T
SUZUKI M
Citation: J. Hamuro et al., SYNERGISTIC ANTIMETASTATIC EFFECTS OF LENTINAN AND INTERLEUKIN-2 WITHPREOPERATIVE AND POSTOPERATIVE TREATMENTS, Japanese journal of cancer research, 85(12), 1994, pp. 1288-1297
Citation: M. Suzuki et al., CURATIVE EFFECTS OF COMBINATION THERAPY WITH LENTINAN AND INTERLEUKIN-2 AGAINST ESTABLISHED MURINE TUMORS, AND THE ROLE OF CD8-POSITIVE T-CELLS, Cancer immunology and immunotherapy, 38(1), 1994, pp. 1-8
Authors:
SUZUKI M
TAKATSUKI F
MAEDA YY
HAMURO J
CHIHARA G
Citation: M. Suzuki et al., ANTITUMOR AND IMMUNOLOGICAL ACTIVITY OF LENTINAN IN COMPARISON WITH LPS, International journal of immunopharmacology, 16(5-6), 1994, pp. 463-468